Perioperative management of a patient with unexpectedly detected early-stage ovarian mucinous carcinoma combined with progressive bulbar paralysis: a case report and literature review
article
OA: gold
CC0
Abstract
BACKGROUND: Giant ovarian cysts (GOCs)complicated with progressive bulbar paralysis (PBP) are very rare, and no such literature about these cases have been reported. Through the diagnosis and treatment of this case, the perioperative related treatment of such patients was analyzed in detail, and early-stage ovarian mucinous carcinoma was unexpectedly found during the treatment, which provided reference for clinical diagnosis and treatment of this kind of diseases. CASE PRESENTATION: In this article, we reported a 38-year-old female patient. The patient was diagnosed with PBP 2 years ago. Examination revealed a large fluid-dominated cystic solid mass in the pelvis measuring approximately 28.6×14.2×8.0 cm. Carbohydrate antigen19-9(CA19-9) 29.20 IU/mL and no other significant abnormalities were observed. The patient eventually underwent transabdominal right adnexal resection under regional anesthesia, epidural block. Postoperative pathology showed mucinous carcinoma in some areas of the right ovary. The patient was staged as stage IA, and surveillance was chosen. With postoperative follow-up 1 month later, her CA19-9 decreased to 14.50 IU/ml. CONCLUSIONS: GOCs combined with PBP patients require a multi-disciplinary treatment. Preoperative evaluation of the patient's PBP progression, selection of the surgical approach in relation to the patient's fertility requirements, the nature of the ovarian cyst and systemic condition are required. Early mucinous ovarian cancer accidentally discovered after operation and needs individualized treatment according to the guidelines and the patient's situation. The patient's dysphagia and respiratory function should be closely monitored during the perioperative period. In addition, moral support from the family is also very important.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
References (22)
- doi:10.4274/balkanmedj.2016.0223 via openalex
- doi:10.3390/ijms20112818 via openalex
- doi:10.1136/ijgc-2021-002565 via openalex
- doi:10.6004/jnccn.2021.0007 via openalex
- doi:10.1016/j.clnu.2017.09.003 via openalex
- doi:10.1016/j.ncl.2020.03.013 via openalex
- doi:10.1016/j.ygyno.2015.09.010 via openalex
- doi:10.1016/j.cca.2015.03.047 via openalex
- doi:10.1186/s12904-019-0433-6 via openalex
- doi:10.3389/fonc.2021.796330 via openalex
- doi:10.1186/s13054-018-2103-0 via openalex
- doi:10.1016/j.ijoa.2018.06.001 via openalex
- doi:10.1136/jnnp-2013-305770 via openalex
- doi:10.1136/ijgc-2020-001817 via openalex
- doi:10.6004/jnccn.2020.0016 via openalex
- doi:10.1016/j.ygyno.2018.08.025 via openalex
- doi:10.1161/circulationaha.116.023262 via openalex
- doi:10.23736/s0375-9393.17.11996-6 via openalex
- doi:10.1101/cshperspect.a024117 via openalex
- doi:10.1016/j.neubiorev.2019.12.032 via openalex
- doi:10.3390/cancers14133210 via openalex
- doi:10.1002/14651858.cd006981.pub3 via openalex
Source provenance
- openalex
- last seen: 2026-05-14T06:26:15.156323+00:00
License: CC0
· commercial use OK